Follow
David C Fajgenbaum
David C Fajgenbaum
Translational Medicine & Human Genetics, University of Pennsylvania
Verified email at pennmedicine.upenn.edu - Homepage
Title
Cited by
Cited by
Year
Cytokine storm
DC Fajgenbaum, CH June
New England Journal of Medicine 383 (23), 2255-2273, 2020
24942020
International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease
DC Fajgenbaum, TS Uldrick, A Bagg, D Frank, D Wu, G Srkalovic, ...
Blood, The Journal of the American Society of Hematology 129 (12), 1646-1657, 2017
4872017
HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy
DC Fajgenbaum, F van Rhee, CS Nabel
Blood, The Journal of the American Society of Hematology 123 (19), 2924-2933, 2014
3492014
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
F Van Rhee, P Voorhees, A Dispenzieri, A Fosså, G Srkalovic, M Ide, ...
Blood, The Journal of the American Society of Hematology 132 (20), 2115-2124, 2018
3092018
Overview of Castleman disease
A Dispenzieri, DC Fajgenbaum
Blood, The Journal of the American Society of Hematology 135 (16), 1353-1364, 2020
2882020
Idiopathic multicentric Castleman's disease: a systematic literature review
AY Liu, CS Nabel, BS Finkelman, JR Ruth, R Kurzrock, F van Rhee, ...
The Lancet Haematology 3 (4), e163-e175, 2016
2842016
Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV‐8‐negative multicentric Castleman disease
N Iwaki, DC Fajgenbaum, CS Nabel, Y Gion, E Kondo, M Kawano, ...
American Journal of Hematology 91 (2), 220-226, 2016
2602016
The full spectrum of Castleman disease: 273 patients studied over 20 years
E Oksenhendler, D Boutboul, D Fajgenbaum, A Mirouse, C Fieschi, ...
British Journal of Haematology 180 (2), 206-216, 2018
1792018
Clinical and pathological characteristics of HIV-and HHV-8–negative Castleman disease
LI Yu, M Tu, J Cortes, ZY Xu-Monette, RN Miranda, J Zhang, RZ Orlowski, ...
Blood, The Journal of the American Society of Hematology 129 (12), 1658-1668, 2017
1702017
Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease
DC Fajgenbaum
Blood, The Journal of the American Society of Hematology 132 (22), 2323-2330, 2018
1262018
International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease
F Van Rhee, E Oksenhendler, G Srkalovic, P Voorhees, M Lim, ...
Blood advances 4 (23), 6039-6050, 2020
1232020
Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6 blockade–refractory idiopathic multicentric Castleman disease
DC Fajgenbaum, RA Langan, AS Japp, HL Partridge, SK Pierson, ...
The Journal of clinical investigation 129 (10), 4451-4463, 2019
992019
Castleman disease pathogenesis
DC Fajgenbaum, D Shilling
Hematology/Oncology Clinics 32 (1), 11-21, 2018
912018
Castleman disease
A Carbone, M Borok, B Damania, A Gloghini, MN Polizzotto, ...
Nature Reviews Disease Primers 7 (1), 84, 2021
852021
Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate
P Mehta, DC Fajgenbaum
Current opinion in Rheumatology 33 (5), 419-430, 2021
742021
Plasma proteomics identifies a ‘chemokine storm’in idiopathic multicentric Castleman disease
SK Pierson, AJ Stonestrom, D Shilling, J Ruth, CS Nabel, A Singh, Y Ren, ...
American journal of hematology 93 (7), 902-912, 2018
702018
Eruptive cherry hemangiomatosis associated with multicentric Castleman disease: a case report and diagnostic clue
DC Fajgenbaum, M Rosenbach, F van Rhee, A Nasir, J Reutter
JAMA dermatology 149 (2), 204-208, 2013
632013
Increased mTOR activation in idiopathic multicentric Castleman disease
DJ Arenas, K Floess, D Kobrin, RAL Pai, MB Srkalovic, MA Tamakloe, ...
Blood, The Journal of the American Society of Hematology 135 (19), 1673-1684, 2020
602020
Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease
L Zhang, A Zhao, M Duan, Z Li, X Cao, J Feng, D Zhou, D Zhong, ...
Blood, The Journal of the American Society of Hematology 133 (16), 1720-1728, 2019
582019
Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic …
Y Nishimura, DC Fajgenbaum, SK Pierson, N Iwaki, A Nishikori, ...
American Journal of Hematology 96 (10), 1241-1252, 2021
542021
The system can't perform the operation now. Try again later.
Articles 1–20